Ordaōs Selected to Participate in AWS Generative AI Accelerator

Ordaōs, a human-enabled, machine-driven drug design company that creates novel and customized mini-proteins, today announced it has been selected to participate in the inaugural cohort of the AWS Generative AI Accelerator, a technical, business, and mentorship program for generative AI-focused startups to help accelerate their cloud-native business. This opportunity will support...

The post Ordaōs Selected to Participate in AWS Generative AI Accelerator first appeared on AI-TechPark.

accelerator ai aws aws generative ai business cloud cloud-native design drug design generative human machine mentorship novel proteins startups support technical